C4 Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies to target and degrade disease-causing proteins, particularly in cancer treatment
By leveraging its proprietary technology platform, C4 Therapeutics aims to create highly selective and effective drug candidates that can modulate the protein environment within cells, offering new hope for patients with various types of cancer and other serious diseases. The company's approach is centered on the principle of targeted protein degradation, which has the potential to transform the therapeutic landscape by eliminating harmful proteins rather than merely inhibiting them.
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48.
Shares of Despegar.com, Corp. (NYSEDESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.
U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose, gaining, 0.20% to 4,653.07.
U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to 14,594.61. The S&P 500 also rose, gaining, 0.14% to 4,650.04.
Shares of ReShape Lifesciences Inc. (NASDAQRSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&P 500 also rose, gaining, 0.26% to 4,634.47.
